RepliCel Life Sciences Inc (REPCF)
0.0428
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
RepliCel Life Sciences Debt to Equity Ratio: -0.0062 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2023 | -0.0062 |
June 30, 2023 | -0.0068 |
March 31, 2023 | -0.0075 |
December 31, 2022 | -0.0069 |
September 30, 2022 | -0.0045 |
June 30, 2022 | -0.0048 |
March 31, 2022 | -0.0049 |
December 31, 2021 | -0.005 |
September 30, 2021 | -0.0052 |
June 30, 2021 | -0.0054 |
March 31, 2021 | -0.0132 |
December 31, 2020 | -0.015 |
September 30, 2020 | -0.0106 |
June 30, 2020 | -0.0117 |
March 31, 2020 | -0.0009 |
December 31, 2019 | 0.00 |
September 30, 2019 | -0.0609 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
Date | Value |
---|---|
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0609
Minimum
Sep 2019
--
Maximum
Jun 2019
-0.0094
Average
-0.0058
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 0.2439M |
Total Liabilities (Quarterly) | 5.127M |
Shareholders Equity (Quarterly) | -4.883M |
Current Ratio | 0.1298 |
Net Debt Paydown Yield | -0.00% |